<DOC>
	<DOCNO>NCT02215837</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy chemotherapy combine autologous tumor Lysate-pulsed dendritic cytokine-induced killer cell ( Ag-D-CIK ) gastric cancer .</brief_summary>
	<brief_title>Study Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy Gastric Cancer</brief_title>
	<detailed_description>40 patient stage Ⅰ～Ⅲ Gastric Cancer , receive surgery keep tumor tissue , randomly divide group A（receive Ag-D-CIK treatment chemotherapy ) group B（just receive chemotherapy ) , randomize ratio 1:1 . Patients group A receive 3 cycle Ag-D-CIK treatment ( every 1 month ) 4 cycle chemotherapy ( every 2 week ) .Patients group B receive 4 cycle chemotherapy（every 2 week ) .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Digestive System Neoplasms</mesh_term>
	<criteria>Patients accept curative operation 18~80 year old Histologically confirm gastric cancer stage Ⅰ~Ⅲ Patients accept radical gastrectomy ; Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 . Hemoglobin＜8.0 g/dL , White blood cell ＜3 x 10^9/L ; Platelet count ＜75 x 10^9/L ; ALT , AST , BUN Cr normal limit 3.0 time Known suspect allergy investigational agent agent give association trial Pregnant lactating patient Known history Human Immunodeficiency Virus ( HIV ) , Hepatitis C Virus ( HCV ) TreponemaPallidun ( TP ) infection Patients suffer serious autoimmune disease Patients use long time use immunosuppressant Patients active infection Patients suffer serious organ dysfunction Patients suffer cancer Other situation researcher consider unsuitable study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Gastric cancer</keyword>
	<keyword>D-CIK</keyword>
	<keyword>Autologous tumor lysate</keyword>
</DOC>